Firms

Taiho Ventures

Taiho Ventures

Corporate venture capital arm of Japan’s Taiho Pharmaceutical investing in early-stage biotechnology companies relevant to oncology, allergy, immunology and urology. It backs therapeutic platforms and drug developers through equity investments, company creation, spin-outs and option-based investments. Its current website reports USD400 million under management; this is aggregate managed capital rather than a newly verified fund close.

Founded
2016
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Hidefumi KasugaInvestment Director
Sakae AsanumaPresident and Chief Executive Officer
Seiji MiyaharaPartner and Senior Investment Director
Takaaki IshiiSenior Investment Director
Takayuki HiranoAssociate Investment Director

Co-investing

Codon Capital
Digitalis Ventures
Aulis Capital

Investments